-
Novartis: Menveo protects infants against meningococcal disease
BASEL, Switzerland An investigative vaccine made by Novartis appears to offer good protection against meningococcal disease in infants, according to results of a late-stage clinical trial released Monday.
The Swiss drug maker said results of a phase-3 trial showed that Menveo (meningococcal group A, C, W135 and Y) induced immune responses in a high percentage of babies against four strains of the bacteria. Meningococcal disease occurs suddenly and can cause serious illness and often death during the first year of life.
-
Cirrus' ClearEars can relieve glue ear
COLD SPRING HARBOR, N.Y. Cirrus Healthcare Products recently announced the launch of ClearEars, earplugs that contain a polymer to draw water from the ears after water activities. Consumers with glue ear, a condition in which thick, sticky fluid collects behind the eardrum, discovered that ClearEars helps to alleviate this condition, the company said.